A Year in Review
Hobamine has claimed the spotlight in the field of cellular health this past year, and TSI Group eagerly anticipates the developments in 2024. Hobamine, TSI Group’s latest ingredient breakthrough, has garnered recognition as one of the standout discoveries of the year. As we take pride in reflecting on the past year, we eagerly anticipate exploring new studies and findings that await on the horizon. But first, let’s revisit some notable highlights from 2023. New Study Shows 2-HOBA has a Promising Impact on Immune Health In a study funded by the NIH and published in the journal Inflammation, it